(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -84.08%4.24K | 82.15%-22.45K | 81.19%-2.11K | -240.24%-236.79K | -61.70%-126.46K | 208.82%26.6K | -22.75%-125.74K | 0.00%-11.19K | 93.43%-69.6K | -4,484.41%-78.21K |
Net income from continuing operations | -354.40%-94.91K | 57.17%-53.96K | 17.38%-50.23K | 87.81%-288.7K | 96.30%-81.02K | 88.50%-20.89K | -20.95%-126K | 0.00%-60.79K | -622.72%-2.37M | -671.82%-2.19M |
Asset impairment expenditure | ---- | ---- | ---- | -99.60%8.57K | ---- | ---- | ---- | ---- | --2.16M | ---- |
Other non cashItems | ---- | ---- | ---- | 68.62%-36.11K | ---- | ---- | ---- | ---- | 81.95%-115.08K | ---115.08K |
Change In working capital | 108.78%99.15K | 12,210.16%31.51K | -2.98%48.12K | -68.72%79.45K | -128.10%-17.9K | -75.05%47.49K | -85.29%256 | 0.00%49.6K | 164.00%253.99K | 229.70%63.7K |
-Change in receivables | -60.21%28.42K | -13.40%-12.04K | -622.46%-39.69K | -70.20%53.14K | -101.73%-2.19K | 37.95%71.44K | -3.69%-10.61K | 0.00%-5.49K | 180.43%178.3K | 1,350.51%126.51K |
-Change in payables and accrued expense | 395.34%70.72K | 300.67%43.55K | 59.38%87.81K | -65.24%26.31K | 75.00%-15.7K | -117.29%-23.95K | -9.24%10.87K | 0.00%55.09K | 143.21%75.7K | -61.10%-62.82K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -84.08%4.24K | 82.15%-22.45K | 81.19%-2.11K | -240.24%-236.79K | -61.70%-126.46K | 208.86%26.6K | -22.75%-125.74K | 0.00%-11.19K | 93.43%-69.6K | -4,484.35%-78.21K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 96.63%-2.97K | -3.89%-156.58K | -851.31%-260.44K | 75.12%-124.87K | 137.70%141.31K | 30.65%-88.1K | -168.74%-150.71K | 0.00%-27.38K | 73.90%-501.84K | -532.70%-374.81K |
Net other investing changes | 96.63%-2.97K | -3.89%-156.58K | -851.31%-260.44K | 75.12%-124.87K | 137.70%141.31K | 30.65%-88.1K | -168.74%-150.71K | 0.00%-27.38K | 73.90%-501.84K | -532.70%-374.81K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 96.63%-2.97K | -3.89%-156.58K | -851.31%-260.44K | 75.12%-124.87K | 137.70%141.31K | 30.65%-88.1K | -168.74%-150.71K | 0.00%-27.38K | 73.90%-501.84K | -532.70%-374.81K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 62.57%779.4K | -117.21%-82.5K | 0 | -82.85%479.41K | 412.02%479.41K | |||||
Net common stock issuance | ---- | ---- | ---- | 62.57%779.4K | -117.21%-82.5K | --0 | ---- | ---- | -82.85%479.41K | 412.02%479.41K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | ---- | ---- | 62.57%779.4K | -117.21%-82.5K | --0 | ---- | ---- | -82.85%479.41K | 412.02%479.41K |
Net cash flow | ||||||||||
Beginning cash position | -79.20%174.03K | 40.48%353.05K | 112.36%615.6K | -31.74%197.86K | 298.48%683.25K | 188.66%836.76K | 0.00%251.31K | 0.00%289.88K | -39.16%289.88K | -66.01%171.47K |
Current changes in cash | 102.05%1.26K | -130.58%-179.03K | -580.75%-262.55K | 553.97%417.74K | -356.26%-67.65K | 48.07%-61.49K | 469.32%585.45K | 0.00%-38.57K | 50.67%-92.02K | 112.30%26.4K |
End cash Position | -74.34%175.29K | -79.20%174.03K | 40.48%353.05K | 211.12%615.6K | 211.12%615.6K | 298.48%683.25K | 801.72%836.76K | 0.00%251.31K | -31.74%197.86K | -31.74%197.86K |
Free cash from | -84.08%4.24K | 82.15%-22.45K | 81.19%-2.11K | -240.24%-236.79K | -61.70%-126.46K | 208.86%26.6K | -22.75%-125.74K | 0.00%-11.19K | 93.43%-69.6K | -4,484.35%-78.21K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data